Abstract:Diabetes is a chronic disease characterized by high serum glucose levels. Chronic and acute hyperglycemia could be critical during the development of diabetic complications. Hesperetin is a type of bioflavonoid‐based flavanone found abundantly in citrus fruits. Hesperetin exhibits many pharmacological properties, including anti‐inflammatory, anticancer, and anti‐vascular formation effects. However, the epigenetic mechanisms mediating the antidiabetic and anti‐inflammation activities of hesperetin are still unknown. In this study, we investigated the effects of hesperetin on pro‐inflammatory cytokine secretion through the nuclear factor (NF)‐κB signaling pathway and the underlying epigenetic mechanisms in differentiated human THP‐1 monocytes treated with high glucose concentrations and LPS. THP‐1 cells were differentiated into macrophages by treatment with phorbol 12‐myristate 13‐acetate (PMA, 1 μM) for 48 h. Differentiated THP‐1 cells were cultured under normoglycemic (NG, 5.5 mmol glucose) or hyperglycemic (HG, 25 mmol glucose) conditions in the absence or presence of hesperetin (10, 25, 50, or 100 μM) for 48 h and then treated with 100 ng/mL LPS 6 h prior to harvesting. Under in vitro conditions mimicking diabetes complications, we found that hesperetin inhibited NF‐κB expression and acetyl p65 levels. Histone acetylases (HATs) and histone deacetylases (HDACs) have been found to play important roles in the regulation of several inflammatory and diabetic target genes by removing an acetyl group from lysine residues of target proteins. SIRT3 and SIRT6 modulate glucose and lipid metabolism. Thus, we examined HAT and HDAC activity using by ELISA. Hesperetin restored histone acetylase (HAT) and HDAC activities, similar to NG conditions, in high glucose‐ and LPS‐treated differentiated THP‐1 cells. High glucose and LPS stimulation increased NF‐κB, SIRT3 and SIRT6 levels and increased HDAC3 levels whereas hesperetin treatment reduced SIRT3 and SIRT6 expression and suppressed HDAC3 expression using western blotting, real‐time pcr and immunofluorescence. Accordingly, we concluded that HDAC3, SIRT3, and SIRT6 could be potent targets for the management of inflammation, infection, diabetes, and diabetic complications. Analysis of post‐transcriptional histone modifications showed that high glucose and LPS increased H3K9ac levels, whereas hesperetin suppressed H3K9ac levels. Based on these findings, we concluded that hesperetin may have applications in the treatment and prevention of diabetes and its complications.

Hesperetin, a SIRT1 activator, inhibits hepatic inflammation via AMPK/CREB pathway

Hesperetin Derivative-14 Alleviates Inflammation by Activating PPAR-γ in Mice with CCl4-induced Acute Liver Injury and LPS-treated RAW264.7 Cells.

Hesperitin Derivative-11 Suppress Hepatic Stellate Cell Activation and Proliferation by Targeting PTEN/AKT Pathway.

Hesperetin Derivative Attenuates CCl4-induced Hepatic Fibrosis and Inflammation by Gli-1-dependent Mechanisms.

Terf2ip Deficiency Accelerates Non-Alcoholic Steatohepatitis Through Regulating Lipophagy and Fatty Acid Oxidation Via Sirt1/AMPK Pathway

Hesperetin Derivative Decreases CCl4‐induced Hepatic Fibrosis by Ptch1‐dependent Mechanisms

Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPKα-Drp1/PINK1-Parkin signaling pathway

Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway

Hesperetin Inhibits Pro‐inflammatory Cytokine Secretion Induced by Lipopolysaccharide in Differentiated Human THP‐1 Monocytes under Hyperglycemic Conditions

Hesperitin attenuates alcoholic steatohepatitis by regulating TLR4/NF-κB signaling in mice

Inhibition of SIRT1 Relieves Hepatocarcinogenesis Via Alleviating Autophagy and Inflammation

Regulation of SIRT1 and Its Roles in Inflammation

Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2

Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis

Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease

Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease

Hesperidin Alleviates Acute Necrotizing Pancreatitis by Activating SIRT1 - Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation

Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in Fibroblasts

Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease

Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis

Hydrogen Sulfide Attenuates Inflammatory Hepcidin By Reducing Il-6 Secretion And Promoting Sirt1-Mediated Stat3 Deacetylation